Mary Panjari

Summary

Affiliation: Monash University
Country: Australia

Publications

  1. doi The safety of 52 weeks of oral DHEA therapy for postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 63:240-5. 2009
  2. doi A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Sex Med 6:2579-90. 2009
  3. ncbi DHEA for postmenopausal women: a review of the evidence
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence, Department of Medicine, Central Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 66:172-9. 2010
  4. doi The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics
    Mary Panjari
    Women s Health Program, Department of Medicine, Monash University Medical School, Alfred Hospital, Commercial Road, Prahran, Vic, Australia
    Horm Cancer 1:93-9. 2010
  5. ncbi Vaginal DHEA to treat menopause related atrophy: a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Maturitas 70:22-5. 2011
  6. ncbi Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
  7. doi Breast cancer survivors' beliefs about the causes of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, Melbourne, Vic, Australia
    Psychooncology 21:724-9. 2012
  8. doi Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment
    Robin J Bell
    Women s Health Research Program, School of Public Health and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria, 3004, Australia
    J Cancer Surviv 8:1-8. 2014
  9. doi A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70+ with those aged <70 years at the time of diagnosis of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, 99 Commercial Rd, Melbourne, VIC 3004, Australia
    J Geriatr Oncol 5:141-7. 2014
  10. doi Sexual function after breast cancer
    Mary Panjari
    Monash University Medical School, Alfred Hospital Women s Health Program, Department of Medicine, Prahran, Victoria, Australia
    J Sex Med 8:294-302. 2011

Detail Information

Publications12

  1. doi The safety of 52 weeks of oral DHEA therapy for postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 63:240-5. 2009
    ..The aim of this study was to evaluate the safety of 52 weeks of DHEA 50mg daily oral dose given to postmenopausal women with low libido to improve sexual function...
  2. doi A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Sex Med 6:2579-90. 2009
    ..Dehydroepiandrosterone (DHEA) and its sulfate DHEAS, which are the most abundant steroids in women, decline with age. We have shown association between low sexual function and low circulating DHEAS levels in women...
  3. ncbi DHEA for postmenopausal women: a review of the evidence
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence, Department of Medicine, Central Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    Maturitas 66:172-9. 2010
    ..It has been proposed that restoring the circulating levels of these steroids to those found in young women may have anti-aging effects and improve sexual function and wellbeing in postmenopausal women...
  4. doi The relationship between hormone therapy use at the time of diagnosis of breast cancer and tumor characteristics
    Mary Panjari
    Women s Health Program, Department of Medicine, Monash University Medical School, Alfred Hospital, Commercial Road, Prahran, Vic, Australia
    Horm Cancer 1:93-9. 2010
    ..01). There were no associations between HT use and either breast cancer stage or HR status. Women using systemic HT at the time of diagnosis were more likely to have lobular rather than ductal breast cancer compared with women not on HT...
  5. ncbi Vaginal DHEA to treat menopause related atrophy: a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
    Maturitas 70:22-5. 2011
    ....
  6. ncbi Methodology and challenges to recruitment to a randomized, double-blind, placebo-controlled trial of oral DHEA in postmenopausal women
    Mary Panjari
    NH and MRC Centre of Clinical Research Excellence in the Women s Health Program, Department of Medicine, Central and Eastern Clinical School, Monash University, Alfred Hospital, Prahran, Victoria, Australia
    J Womens Health (Larchmt) 17:1559-65. 2008
    ..To report on the issues encountered in the recruitment of healthy naturally menopausal women in the community to a randomized placebo-controlled trial of dehydroepiandrosterone (DHEA) therapy for treatment of loss of sexual desire...
  7. doi Breast cancer survivors' beliefs about the causes of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, Melbourne, Vic, Australia
    Psychooncology 21:724-9. 2012
    ..To explore the beliefs held by breast cancer (BC) survivors about the factors that contribute to the development of their BC. ‚ÄČ..
  8. doi Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment
    Robin J Bell
    Women s Health Research Program, School of Public Health and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria, 3004, Australia
    J Cancer Surviv 8:1-8. 2014
    ..The aim of our study was to establish the prevalence of breast pain persisting 5 years after the initial treatment of breast cancer (BC) and the relationship between those persistent symptoms and general well-being...
  9. doi A comparison of the characteristics, treatment and outcome after 5 years, of Australian women aged 70+ with those aged <70 years at the time of diagnosis of breast cancer
    Mary Panjari
    Women s Health Research Program, Monash University, 99 Commercial Rd, Melbourne, VIC 3004, Australia
    J Geriatr Oncol 5:141-7. 2014
    ..We present 5-year follow-up data from women aged 70 years or older (70+), at the time of diagnosis of their BC, compared with younger women (<70 years)...
  10. doi Sexual function after breast cancer
    Mary Panjari
    Monash University Medical School, Alfred Hospital Women s Health Program, Department of Medicine, Prahran, Victoria, Australia
    J Sex Med 8:294-302. 2011
    ..Breast cancer (BC) remains the most common non-skin cancer in women and an increasing number are living as BC survivors...
  11. doi Clinical review: DHEA replacement for postmenopausal women
    Susan R Davis
    Women s Health Research Program, Department of Epidemiology and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, Victoria 3004, Australia
    J Clin Endocrinol Metab 96:1642-53. 2011
    ..We have summarized the physiology of DHEA in women and reviewed the findings from randomized controlled trials (RCT) of the effects of DHEA therapy in postmenopausal women with normal adrenal function...
  12. doi Sexual function, incontinence, and wellbeing in women after rectal cancer--a review of the evidence
    Mary Panjari
    Women s Health Research Program, School of Public Health and Preventive Medicine, Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
    J Sex Med 9:2749-58. 2012
    ....